FDA will increase postmarketing surveillance of drugs

Benzer Materyaller

• FDA proposes higher fees for drug approvals to cover postmarketing surveillance
  Yazar:: Tanne, Janice Hopkins
  Baskı/Yayın Bilgisi: (2007)
• FDA places “black box” warning on antidiabetes drugs
  Yazar:: Tanne, Janice Hopkins
  Baskı/Yayın Bilgisi: (2007)
• FDA committees say keep rosiglitazone available but increase warnings
  Yazar:: Tanne, Janice Hopkins
  Baskı/Yayın Bilgisi: (2007)
• FDA works with US health insurers to identify drug problems
  Yazar:: Tanne, Janice Hopkins
  Baskı/Yayın Bilgisi: (2008)
• FDA calls for warnings on anaemia drugs amid reports of incentives to doctors
  Yazar:: Tanne, Janice Hopkins
  Baskı/Yayın Bilgisi: (2007)